Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network. [PDF]
Turner C +12 more
europepmc +1 more source
Comparison of safety and immunogenicity between high-dose and low-dose quadrivalent influenza vaccines in children aged 6-35 months in China: A randomized, double-blind clinical study. [PDF]
Guo X +16 more
europepmc +1 more source
Sustaining Local Production of Influenza Vaccines: A Global Study of Enabling Factors Among Vaccine Manufacturers. [PDF]
Chadwick C +5 more
europepmc +1 more source
Effectiveness of live-attenuated and inactivated influenza vaccines against influenza in 2-17-y-old children, United States, 2022-2025. [PDF]
Kitano T, Yoshida S.
europepmc +1 more source
Related searches:
Quadrivalent influenza nanoparticle vaccines induce broad protection
Nature, 2021Kelly Lee, Masaru Kanekiyo, David Baker
exaly
Next-generation influenza vaccines: opportunities and challenges
Nature Reviews Drug Discovery, 2020Barney S. Graham +2 more
exaly

